PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

NCT02483884 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Prostate Cancer

Interventions

DRUG: [68Ga]RM2
PROCEDURE: PET/CT

Sponsor

Life Molecular Imaging SA